AAREY DRUGS & PHARMACEUTICALS
Back to Income Statement
|
AAREY DRUGS & PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹398 Cr | ₹419 Cr | ₹493 Cr | ₹34,841,641 Cr | ₹300 Cr |
What is the latest Revenue of AAREY DRUGS & PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹398 Cr |
| Mar2024 | ₹419 Cr |
| Mar2023 | ₹493 Cr |
| Mar2022 | ₹34,841,641 Cr |
| Mar2021 | ₹300 Cr |
How is Revenue of AAREY DRUGS & PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹398 Cr | -5.09 | |
| Mar2024 | ₹419 Cr | -14.98 | |
| Mar2023 | ₹493 Cr | -100.00 | |
| Mar2022 | ₹34,841,641 Cr | 11,610,336.07 | |
| Mar2021 | ₹300 Cr | - | |
Compare Revenue of peers of AAREY DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AAREY DRUGS & PHARMACEUTICALS | ₹202.1 Cr | 7.1% | -18.2% | 24.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,131.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,862.0 Cr | 2.9% | 1.8% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,254.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹121,198.0 Cr | 0.2% | -0.2% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,083.0 Cr | 0.9% | 4.8% | -3.2% | Stock Analytics | |
AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AAREY DRUGS & PHARMACEUTICALS | 7.1% |
-18.2% |
24.8% |
| SENSEX | 1% |
0.3% |
6.7% |
You may also like the below Video Courses